ClinicalTrials.gov
public full text
Public Domain
Analysis of Cytokine Expression Pattern in Systemic Sclerosis
By contrast to other proinflammatory cytokines which are found up-regulated in the skin of patients with psoriasis, atopic dermatitis or systemic sclerosis, IL-34 is the only cytokine that undergoes down-regulation. This finding is interesting regarding the description of IL-34 as an immunosuppressive cytokine. In this study, the expression and the role of interleukin-34 (IL-34) will be investigated in the physiopathology of systemic sclerosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Interleukin-34 in Stage I and II Periodontitis#991908
- Etude de l'impact d'une déficience en interleukine-34 sur le développement et les réponses immunes#471966
- Allergic Rhinitis, Immunotherapy and Vitamin d#875721
- Sonelokimab, an IL-17A- and IL-17F- inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial#244551
- Selective immune modulation in seminal plasma during simian immunodeficiency virus infection despite systemic inflammation#454238
Record · ID 898102
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive